TY - JOUR
T1 - Explaining end-users' intentions to use innovative medical and food biotechnology products
AU - Mulder, Bob C.
AU - Poortvliet, P. Marijn P.M.
AU - Lugtig, Peter
AU - De Bruin, Marijn
PY - 2014/8
Y1 - 2014/8
N2 - Low public acceptance hinders the successful introduction of biotechnological innovations, such as genetically modified foods or vaccinations against infectious diseases. Earlier studies indicated that a lack of knowledge is not a key barrier to acceptance. This was confirmed in the current study, which examined an integrated theoretical model tested among 579 participants from the Dutch public. The results suggest that communication strategies should instead target attitudes, social norms, and risk perceptions, and appeal to people's tendency (or lack thereof) to be innovative.
AB - Low public acceptance hinders the successful introduction of biotechnological innovations, such as genetically modified foods or vaccinations against infectious diseases. Earlier studies indicated that a lack of knowledge is not a key barrier to acceptance. This was confirmed in the current study, which examined an integrated theoretical model tested among 579 participants from the Dutch public. The results suggest that communication strategies should instead target attitudes, social norms, and risk perceptions, and appeal to people's tendency (or lack thereof) to be innovative.
UR - http://www.scopus.com/inward/record.url?scp=84905366272&partnerID=8YFLogxK
U2 - 10.1002/biot.201400224
DO - 10.1002/biot.201400224
M3 - Article
AN - SCOPUS:84905366272
SN - 1860-6768
VL - 9
SP - 997
EP - 999
JO - Biotechnology Journal
JF - Biotechnology Journal
IS - 8
ER -
